Etifoxine
| Title | Journal |
|---|---|
| Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. | Journal of neuroendocrinology 20120101 |
| Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. | Journal of neuroendocrinology 20120101 |
| Progesterone synthesis in the nervous system: implications for myelination and myelin repair. | Frontiers in neuroscience 20120101 |
| In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control. | Drug testing and analysis 20111001 |
| Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits? | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110601 |
| Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical. | Journal of pain research 20110101 |
| Acupuncture Attenuates Anxiety-Like Behavior by Normalizing Amygdaloid Catecholamines during Ethanol Withdrawal in Rats. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress. | Frontiers in neuroscience 20110101 |
| Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor. | Frontiers in neuroscience 20110101 |
| Neurosteroids as neuromodulators in the treatment of anxiety disorders. | Frontiers in endocrinology 20110101 |
| Role of neuroactive steroids in the peripheral nervous system. | Frontiers in endocrinology 20110101 |
| Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice. | Behavioural brain research 20100402 |
| Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia. | The Journal of pharmacology and experimental therapeutics 20100301 |
| Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids. | Pain 20091215 |
| Etifoxine (Stresam) for chemotherapy-induced pain? | Pain 20091215 |
| General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints. | Journal of separation science 20090901 |
| Preventive and curative effects of etifoxine in a rat model of brain oedema. | Clinical and experimental pharmacology & physiology 20090701 |
| The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice. | Alcohol (Fayetteville, N.Y.) 20090501 |
| Adjustment Disorder: epidemiology, diagnosis and treatment. | Clinical practice and epidemiology in mental health : CP & EMH 20090101 |
| [Lymphocytic colitis probably due to etifoxine. A case with relapse after reintroduction]. | Therapie 20090101 |
| [Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABA A-related mechanistic probes. | Psychopharmacology 20080501 |
| [Etifoxine: a new look at the GABA receptor and anxiety]. | L'Encephale 20080401 |
| Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats. | Brain research 20071212 |
| Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents. | Neuroscience research 20060901 |
| Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. | Pharmacoepidemiology and drug safety 20060701 |
| Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. | Human psychopharmacology 20060401 |
| The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. | Pharmacology, biochemistry, and behavior 20051201 |
| Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats. | Physiology & behavior 20041015 |
| Effects of stress and etifoxine on pentobarbital-induced loss of righting reflex in Balb/cByJ and C57BL/6J mice. | Neuroscience letters 20031219 |
| [Etifoxine chlorhydrate-induced acute hepatitis]. | Gastroenterologie clinique et biologique 20031101 |
| The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit. | Neuropharmacology 20030901 |
| Effects of etifoxine on ligand binding to GABA(A) receptors in rodents. | Neuroscience research 20021001 |
| A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected]. | Fundamental & clinical pharmacology 20010601 |
| Functional modulation of gamma-aminobutyric acid(A) receptors by etifoxine and allopregnanolone in rodents. | Neuroscience letters 20010406 |
| Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam. | Arzneimittel-Forschung 19850101 |